2-hydroxyestradiol 17-sulfate has been researched along with Pre-Eclampsia in 2 studies
*Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takanashi, K | 1 |
| Honjo, H; Honma, T; Kashiwagi, T; Takanashi, K; Yoshizawa, I | 1 |
1 review(s) available for 2-hydroxyestradiol 17-sulfate and Pre-Eclampsia
| Article | Year |
|---|---|
[Studies on 2-hydroxyestradiol 17-sulfate derived from fetoplacental unit: the antioxidant as a potential defense substance against preeclampsia].
Topics: Animals; Antioxidants; Catechols; Estradiol; Female; Humans; Hydroxylation; Lipid Peroxidation; Microsomes, Liver; Placenta; Pre-Eclampsia; Pregnancy; Rats | 2003 |
1 trial(s) available for 2-hydroxyestradiol 17-sulfate and Pre-Eclampsia
| Article | Year |
|---|---|
Detection and measurement of urinary 2-hydroxyestradiol 17-sulfate, a potential placental antioxidant during pregnancy.
Topics: Adolescent; Adult; Antioxidants; Chromatography, High Pressure Liquid; Electrochemistry; Estradiol; Female; Humans; Placenta; Pre-Eclampsia; Pregnancy; Radioimmunoassay | 2000 |